Trials / Recruiting
RecruitingNCT05170126
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
ZEPOSIA® (Ozanimod) Pregnancy Registry: A Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,182 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.
Conditions
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2032-06-30
- Completion
- 2032-06-30
- First posted
- 2021-12-27
- Last updated
- 2025-11-20
Locations
3 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT05170126. Inclusion in this directory is not an endorsement.